Search research articles
Contact Us
Filters
Showing results (111-120 of 145) with videos related to
Page
of 15
Sort By:
Science (New York, N.Y.)
|
November 14, 2024
Sequence modeling and design from molecular to genome scale with Evo
Eric Nguyen, Michael Poli, Matthew G Durrant, et al.
Nature Methods
|
December 22, 2022
Bioprinted 3D outer retina barrier uncovers RPE-dependent choroidal phenotype in advanced macular degeneration
Min Jae Song, Russ Quinn, Eric Nguyen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 9, 2017
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme
Christophe Hézode, Pascal Lebray, Victor De Ledinghen, et al.
JHEP Reports : Innovation in Hepatology
|
March 20, 2023
TACE and conformal radiotherapy <i>vs</i>. TACE alone for hepatocellular carcinoma: A randomised controlled trial
Cyrille Féray, Loic Campion, Philippe Mathurin, et al.
Journal of Hepatology
|
December 3, 2014
Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial
Thierry Thévenot, Christophe Bureau, Frédéric Oberti, et al.
The Lancet. Gastroenterology & Hepatology
|
February 24, 2022
Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study
Alexandre Louvet, Julien Labreuche, Christophe Moreno, et al.
European Journal of Gastroenterology & Hepatology
|
August 14, 2023
Unresectable hepatocellular carcinoma at dawn of immunotherapy era: real-world data from the French prospective CHIEF cohort
Eric Nguyen-Khac, Pierre Nahon, Olivier Ganry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 26, 2019
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study
Tarik Asselah, Stanislas Pol, Christophe Hezode, et al.
Journal of Hepatology
|
August 10, 2018
Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis
Nathalie Ganne-Carrié, Cendrine Chaffaut, Valérie Bourcier, et al.
The Lancet. Gastroenterology & Hepatology
|
April 8, 2019
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
Philippe Merle, Jean-Frederic Blanc, Jean-Marc Phelip, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 145) with videos related to
Sort By:
Page
of 15
Science (New York, N.Y.)
|
November 14, 2024
Sequence modeling and design from molecular to genome scale with Evo
Eric Nguyen, Michael Poli, Matthew G Durrant, et al.
Nature Methods
|
December 22, 2022
Bioprinted 3D outer retina barrier uncovers RPE-dependent choroidal phenotype in advanced macular degeneration
Min Jae Song, Russ Quinn, Eric Nguyen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 9, 2017
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme
Christophe Hézode, Pascal Lebray, Victor De Ledinghen, et al.
JHEP Reports : Innovation in Hepatology
|
March 20, 2023
TACE and conformal radiotherapy <i>vs</i>. TACE alone for hepatocellular carcinoma: A randomised controlled trial
Cyrille Féray, Loic Campion, Philippe Mathurin, et al.
Journal of Hepatology
|
December 3, 2014
Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial
Thierry Thévenot, Christophe Bureau, Frédéric Oberti, et al.
The Lancet. Gastroenterology & Hepatology
|
February 24, 2022
Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study
Alexandre Louvet, Julien Labreuche, Christophe Moreno, et al.
European Journal of Gastroenterology & Hepatology
|
August 14, 2023
Unresectable hepatocellular carcinoma at dawn of immunotherapy era: real-world data from the French prospective CHIEF cohort
Eric Nguyen-Khac, Pierre Nahon, Olivier Ganry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 26, 2019
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study
Tarik Asselah, Stanislas Pol, Christophe Hezode, et al.
Journal of Hepatology
|
August 10, 2018
Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis
Nathalie Ganne-Carrié, Cendrine Chaffaut, Valérie Bourcier, et al.
The Lancet. Gastroenterology & Hepatology
|
April 8, 2019
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
Philippe Merle, Jean-Frederic Blanc, Jean-Marc Phelip, et al.
Page
of 15